HBM Healthcare Investments (XSWX:HBMNE) Cyclically Adjusted Revenue per Share: CHF22.36 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:HBMNE HBM Healthcare Investments Ltd XSWX:HBMNE
33 GF Score
Price CHF252.50
! 6 Warning Signs
View Full Analysis

What is HBM Healthcare Investments Cyclically Adjusted Revenue per Share?

HBM Healthcare Investments XSWX:HBMNE 33 Cyclically Adjusted Revenue per Share is CHF22.36 as of Mar. 2026. GuruFocus rates XSWX:HBMNE with a GF Score™ of 33/100. The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

HBM Healthcare Investments's adjusted revenue per share for the three months ended in Mar. 2026 was CHF-2.097. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is CHF22.36 for the trailing ten years ended in Mar. 2026.

During the past 12 months, HBM Healthcare Investments's average Cyclically Adjusted Revenue Growth Rate was 20.50% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -3.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -5.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of HBM Healthcare Investments was 24.70% per year. The lowest was -11.10% per year. And the median was 0.50% per year.

As of today (2026-07-26), HBM Healthcare Investments's current stock price is CHF252.50. HBM Healthcare Investments's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was CHF22.36. HBM Healthcare Investments's Cyclically Adjusted PS Ratio of today is 11.29.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of HBM Healthcare Investments was 16.57. The lowest was 6.44. And the median was 10.65.


HBM Healthcare Investments  (XSWX:HBMNE) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

HBM Healthcare Investments's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=252.50/22.36
=11.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of HBM Healthcare Investments was 16.57. The lowest was 6.44. And the median was 10.65.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


HBM Healthcare Investments Cyclically Adjusted Revenue per Share Related Terms


HBM Healthcare Investments Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for HBM Healthcare Investments's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HBM Healthcare Investments Cyclically Adjusted Revenue per Share Chart

HBM Healthcare Investments Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.14 29.67 22.31 18.80 22.36

HBM Healthcare Investments Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.80 15.04 18.31 21.72 22.36

XSWX:HBMNE vs BLK, BX, KKR: Cyclically Adjusted Revenue per Share Comparison

For the Asset Management subindustry, HBM Healthcare Investments's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HBM Healthcare Investments Cyclically Adjusted PS Ratio vs Asset Management Industry

For the Asset Management industry and Financial Services sector, HBM Healthcare Investments's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where HBM Healthcare Investments's Cyclically Adjusted PS Ratio falls into.


XSWX:HBMNE
33GF Score
HBM Healthcare Investments Ltd XSWX:HBMNE
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HBM Healthcare Investments Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, HBM Healthcare Investments's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-2.097/108.0600*108.0600
=-2.097

Current CPI (Mar. 2026) = 108.0600.

HBM Healthcare Investments Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201512 27.246 99.386 29.624
201603 -10.092 99.475 -10.963
201606 -3.089 100.088 -3.335
201609 6.753 99.604 7.326
201612 -6.301 99.380 -6.851
201703 21.074 100.040 22.763
201706 -10.168 100.285 -10.956
201803 0.000 100.836 0.000
201806 9.618 101.435 10.246
201809 15.939 101.246 17.012
201812 -13.666 100.906 -14.635
201903 18.735 101.571 19.932
201906 10.876 102.044 11.517
201909 3.985 101.396 4.247
201912 23.524 101.063 25.153
202003 -11.622 101.048 -12.429
202006 32.525 100.743 34.887
202009 31.013 100.585 33.318
202012 29.281 100.241 31.565
202103 17.331 100.800 18.579
202106 19.594 101.352 20.891
202109 19.392 101.533 20.639
202112 0.692 101.776 0.735
202203 -50.674 103.205 -53.058
202206 7.450 104.783 7.683
202209 -12.263 104.835 -12.640
202212 -17.274 104.666 -17.834
202303 1.260 106.245 1.282
202306 -1.487 106.576 -1.508
202309 -8.443 106.570 -8.561
202312 -12.514 106.461 -12.702
202403 22.813 107.355 22.963
202406 3.812 107.991 3.814
202409 -0.324 107.468 -0.326
202412 6.547 107.128 6.604
202503 -7.008 107.722 -7.030
202506 -20.761 108.075 -20.758
202509 35.313 107.710 35.428
202512 28.756 107.200 28.987
202603 -2.097 108.060 -2.097

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of CHF22.36 mean?
HBM Healthcare Investments (XSWX:HBMNE) has a Cyclically Adjusted Revenue per Share of CHF22.36 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on HBM Healthcare Investments and its competitors.
Is HBM Healthcare Investments' Cyclically Adjusted Revenue per Share too high?
HBM Healthcare Investments' current Cyclically Adjusted Revenue per Share is CHF22.36. Overall, HBM Healthcare Investments has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does HBM Healthcare Investments' Cyclically Adjusted Revenue per Share compare to BLK and BX?
HBM Healthcare Investments' Cyclically Adjusted Revenue per Share of CHF22.36 can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for an Asset Management company?
A good Cyclically Adjusted Revenue per Share depends on the Asset Management industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on HBM Healthcare Investments and its competitors. HBM Healthcare Investments's current Cyclically Adjusted Revenue per Share is CHF22.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HBM Healthcare Investments stock overvalued right now?
HBM Healthcare Investments (XSWX:HBMNE) has a current Cyclically Adjusted Revenue per Share of CHF22.36. The current Cyclically Adjusted Revenue per Share is CHF22.36. HBM Healthcare Investments' overall GF Score™ is 33/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For HBM Healthcare Investments (XSWX:HBMNE), the current Cyclically Adjusted Revenue per Share is CHF22.36 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HBM Healthcare Investments Business Description

Other Exchanges HBMBF:USAHBMN:Switzerland
Address Bundesplatz 1, Zug, CHE, 6300
HBM Healthcare Investments Ltd is a Switzerland-based holding company. The firm actively invests in the human medicine, biotechnology, medical technology, and diagnostics sectors and related areas. The company holds and manages an international portfolio of companies.
33GF Score

Get the complete analysis for XSWX:HBMNE

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF252.50
Price